Mirum Pharmaceuticals, Inc. (MIRM)
88.95
+0.44
(+0.50%)
USD |
NASDAQ |
Mar 23, 10:20
Mirum Pharmaceuticals EPS Diluted (Quarterly) : -0.111 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Insmed, Inc. | -1.538 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| BridgeBio Pharma, Inc. | -0.9964 |
| XOMA Royalty Corp. | 0.2586 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.73M |
| Revenue (Quarterly) | 148.93M |
| Total Expenses (Quarterly) | 154.66M |
| Enterprise Value | 5.277B |
| Gross Profit Margin (Quarterly) | 80.97% |
| Profit Margin (Quarterly) | -3.85% |
| Earnings Yield | -0.54% |
| Normalized Earnings Yield | -0.5375 |